KMTS Insider Trading Activity and SEC Form 4 Filings
KMTS insider trading summary
Over the past 12 months, insiders at Kestra Medical Technologies, Ltd. (KMTS) reported 47 sales worth $13.9M by 11 insiders and no open-market purchases on SEC Form 4. Net insider selling was $13.9M.
Latest KMTS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Timothy P. Moran | Chief Business Officer | Sell | $94K (3,192 @ $29.56) |
| Oct 29, 2026 | Vaseem Mahboob | Chief Financial Officer | Sell | $147K (4,788 @ $30.60) |
| Oct 28, 2026 | Vaseem Mahboob | Chief Financial Officer | Sell | $1.2M (39,903 @ $30.48) |
| Oct 27, 2026 | Traci S Umberger | See Remarks | Sell | $901K (30,000 @ $30.03) |
| Oct 27, 2026 | Vaseem Mahboob | Chief Financial Officer | Sell | $1.0M (34,809 @ $30.04) |
| Oct 21, 2026 | Traci S Umberger | See Remarks | Sell | $2.6M (96,404 @ $27.15) |
| Oct 21, 2026 | Traci S Umberger | See Remarks | Sell | $101K (3,596 @ $28.09) |
| Oct 20, 2026 | Brian Daniel Webster | See Remarks | Sell | $50K (1,684 @ $29.89) |
| Oct 20, 2026 | Brian Daniel Webster | See Remarks | Sell | $393K (13,316 @ $29.52) |
| Sep 30, 2026 | Raymond W Cohen | Insider | Sell | $98K (3,330 @ $29.28) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.